XAVIER
SORIA GILI
CON
![Foto de XAVIER](/img/nophoto.png)
![Foto de Hospital Universitari de Bellvitge](/img/noimage_org.png)
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (3)
2022
-
M-CSF as a therapeutic target in BRAFV600E melanoma resistant to BRAF inhibitors
British Journal of Cancer
2020
-
Incidence of melanoma in catalonia, Spain, Is rapidly increasing in the elderly population. A multicentric cohort study
Journal of Clinical Medicine, Vol. 9, Núm. 11, pp. 1-11
-
T-Type Calcium Channels as Potential Therapeutic Targets in Vemurafenib-Resistant BRAFV600E Melanoma
Journal of Investigative Dermatology, Vol. 140, Núm. 6, pp. 1253-1265